1 May 2019

UCB and University of Lille anti-tau immunotherapy research highlighted in prestigious international scientific journal ‘Brain’

Read More
25 Apr 2019

UCB's General Meeting of Shareholders

Read More
24 Apr 2019

New Data Showcases the Value of CIMZIA® (certolizumab pegol) in Patients with Psoriasis 

Read More
10 Apr 2019

Transparency notification BlackRock, Inc.

Read More
9 Apr 2019

FDA Approves Evenity™ (Romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

Read More
8 Apr 2019

Transparency notification BlackRock, Inc.

Read More
4 Apr 2019

Acquisition of own shares

Read More
2 Apr 2019

Transparency notifications BlackRock, Inc.

Read More
31 Mar 2019

UCB to provide additional information to the US FDA regarding midazolam nasal spray submission

Read More
29 Mar 2019

Transparency notification BlackRock, Inc.

Read More
Subscribe to